Literature DB >> 22683129

Diabetes and cognitive dysfunction.

Rory J McCrimmon1, Christopher M Ryan, Brian M Frier.   

Abstract

Cognitive dysfunction in type 1 and type 2 diabetes share many similarities, but important differences do exist. A primary distinguishing feature of type 2 diabetes is that people with this disorder often (but not invariably) do poorly on measures of learning and memory, whereas deficits in these domains are rarely seen in people with type 1 diabetes. Chronic hyperglycaemia and microvascular disease contribute to cognitive dysfunction in both type 1 and type 2 diabetes, and both disorders are associated with mental and motor slowing and decrements of similar magnitude on measures of attention and executive functioning. Additionally, both types are characterised by neural slowing, increased cortical atrophy, microstructural abnormalities in white matter tracts, and similar, but not identical, changes in concentrations of brain neurometabolites. Disconcertingly, the rapid rise in obesity and type 2 diabetes in all age groups might result in a substantial increase in prevalence of diabetes-related cognitive dysfunction.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683129     DOI: 10.1016/S0140-6736(12)60360-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  276 in total

1.  Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications.

Authors:  Timothy M Hughes; Christopher M Ryan; Howard J Aizenstein; Karen Nunley; Peter J Gianaros; Rachel Miller; Tina Costacou; Elsa S Strotmeyer; Trevor J Orchard; Caterina Rosano
Journal:  J Diabetes Complications       Date:  2013-08-30       Impact factor: 2.852

2.  Type-2 diabetes mellitus reduces cortical thickness and decreases oxidative metabolism in sensorimotor regions after stroke.

Authors:  Jennifer K Ferris; Sue Peters; Katlyn E Brown; Katherine Tourigny; Lara A Boyd
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-12       Impact factor: 6.200

Review 3.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 4.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

5.  Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.

Authors:  Ronan T Grimes; Kathleen Bennett; Lesley Tilson; Cara Usher; Susan M Smith; Martin C Henman
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 6.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

Review 7.  Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.

Authors:  Anne-Claire Dorsemans; David Couret; Anaïs Hoarau; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Nicolas Diotel
Journal:  Neurogenesis (Austin)       Date:  2017-01-31

Review 8.  Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Authors:  Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs
Journal:  J Int Neuropsychol Soc       Date:  2014-02-20       Impact factor: 2.892

9.  Sex-specific effects of high-fat diet on cognitive impairment in a mouse model of VCID.

Authors:  Abigail E Salinero; Lisa S Robison; Olivia J Gannon; David Riccio; Febronia Mansour; Charly Abi-Ghanem; Kristen L Zuloaga
Journal:  FASEB J       Date:  2020-09-16       Impact factor: 5.191

10.  Detecting subtle fingertip sensory and motor dysfunction in adults with type II diabetes.

Authors:  Stacey L Gorniak; Aisha Khan; Nereyda Ochoa; Morali D Sharma; Cecile L Phan
Journal:  Exp Brain Res       Date:  2014-01-28       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.